Clinical Trials Directory

Trials / Suspended

SuspendedNCT06750146

Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis

French Prospective Study on Biliary Tract Drainage Guided by Endoscopic Ultrasound in Patients With Malignant Biliary Stenosis (RAINBOW)

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
162 (estimated)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is designed to highlight the effectiveness of the Hot AXIOS™ stent when used in accordance with standard medical practice on the evolution of the quality of life of patients with malignant biliary stenosis requiring drainage of the bile ducts after failure of ERCP, in the two months after stent placement.

Detailed description

The study will evaluate the quality of life in patients with malignant biliary obstruction after the placement of a lumen-apposing metal stent via endoscopic ultrasound, with an emphasis on the improvement of quality of life measured as a reduction in jaundice. Improvement in jaundice is a direct indicator of effective bile drainage and is expected to correlate with an enhancement in overall quality of life. Quality of life will be measured by means of subject response to the EORTC QLQ-BIL21, a component of the European Organization for Research and Treatment of Cancer (EORTC) designed specifically to assess the quality of life in patients with biliary tract cancer. The QLQ-BIL21 consists of 21 questions which aim to evaluate specific symptoms and issues relevant to patients with biliary tract cancer, such as jaundice, pain, digestive problems and the psychosocial impact of the disease.

Conditions

Interventions

TypeNameDescription
DEVICEHot AXIOS™ Stent and Electrocautery Enhanced Delivery SystemThe Hot AXIOS™ Stent and Electrocautery Enhanced Delivery System is commercially available and can be used to bridge two lumens or organs to create an internal drain, so as to drain the bile ducts in case of failure of ERCP.

Timeline

Start date
2025-06-19
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2024-12-27
Last updated
2026-04-17

Locations

18 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06750146. Inclusion in this directory is not an endorsement.